The AlphaLISA™ SureFire® Biotin-Free Mouse Total NLRP3 assay is a sandwich immunoassay for quantitative detection of total NLRP3 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Mouse Total NLRP3 assay is a sandwich immunoassay for quantitative detection of total NLRP3 in cellular lysates using Alpha Technology.
Loading...
NLRP3 (NOD-like Receptor Pyrin Domain-Containing 3) is a cytosolic pattern recognition receptor and the most extensively studied member of the NLR family that forms the core component of the NLRP3 inflammasome, a multiprotein innate immune signaling complex. NLRP3 is activated by a broad range of danger signals including ATP, uric acid crystals, cholesterol crystals, silica, asbestos, and mitochondrial reactive oxygen species, following a two-signal model in which an initial priming signal (typically NF-κB activation) upregulates NLRP3 expression and a second activation signal triggers inflammasome assembly. Upon activation, NLRP3 oligomerizes and recruits the adaptor protein ASC and pro-caspase-1 to form the inflammasome complex, leading to caspase-1 activation, proteolytic processing of pro-IL-1β and pro-IL-18 into their mature secreted forms, and induction of pyroptotic cell death through gasdermin D cleavage. NLRP3 inflammasome activation drives pathological inflammation in a wide range of diseases including gout, atherosclerosis, type 2 diabetes, Alzheimer's disease, Parkinson's disease, and inflammatory bowel disease. Selective NLRP3 inhibitors such as MCC950 (CMPD-4) and clinical-stage compounds including inzomelid and selnoflast are under active investigation as anti-inflammatory therapeutics across multiple indications.
The AlphaLISA SureFire Biotin-Free Mouse Total NLRP3 Detection Kit is a sandwich immunoassay for the quantitative detection of total NLRP3 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
RAW 264.7 cells were seeded in a 96 well plate (60,000 cells/well) in complete medium and incubated for 48 hours at 37°C, 5% CO2.Cells were treated with 500 ng/mL of LPS for the indicated time points.
After treatment, the cells were lysed with Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Total and Aggregate NLRP3 levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 1,200 cells (Total), 40,000 cells (Aggregate)) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
LPS treatment induced NLRP3 expression and aggregation within 1 hour, peaking at 4 hours of treatment.
RAW 264.7 cells were seeded in T25 cell culture flasks and cultured to 90% confluency in complete medium at 37°C, 5% CO2.Cells were left untreated or treated with LPS (500 ng/mL, 4h), Nigericin (10 µM, 1h) or LPS + Nigericin (LPS 4h + Nig 1h).
After treatment, each flask was lysed with 3 mL Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Total and Aggregate NLRP3 levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 5,000 cells (Total) or 25,000 cells (Aggregate) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
LPS induced a significant increase in Total and Aggregate NLRP3 levels, while treatment with LPS + Nigericin triggered a further 2-fold increase in Aggregate NLRP3 levels.
RAW 264.7 cells were seeded in a 96 well plate (60,000 cells/well) in complete medium and incubated for 24 hours at 37°C, 5% CO2.Cells were treated with increasing concentrations of LPS for 4 hours.
After treatment, the cells were lysed with Lysis Buffer for 10 minutes at RT with shaking (350 rpm). Total and Aggregate NLRP3, and ERK Total levels were evaluated using respective AlphaLISA SureFire Biotin Free assays. For the detection step, 10 µL of cell lysate (approximately 1,200 cells (Total), 40,000 cells (Aggregate), or 12,000 cells (ERK)) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
LPS triggered a dose-dependent increase of Total and Aggregate NLRP3 levels while ERK Total levels remained unchanged.
Adherent cells were seeded in a 96-well plate (40,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Suspension cells were harvested, washed, and seeded in a 96-well plate (400,000 cells/well) in HBSS.
Cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). NLRP3 Total levels were evaluated using the AlphaLISA SureFire Ultra Biotin Free assay. For the detection step, 10 µL of cell lysate (4,000 adherent cells or 40,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, NLRP3 expression levels were only detected in RAW 264.7 cells.
Cell lysate was prepared from RAW 264.7 cells seeded in T175 flasks and cultured to confluence at 37°C, 5% CO2.Cells were then treated with 500 ng/mL LPS for 4 hours and lysed in 3 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysates were serially diluted in Lysis Buffer and NLRP3 levels were evaluated using the AlphaLISA SureFire Biotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells/datapoint is indicated on the graph. The assay can detect NLRP3 down to approximately 100 cells/datapoint. Assay background is represented with a dotted line.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
NLRP3
|
| Target Class |
Phosphoproteins
|
| Target Species |
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Autoimmunity
Inflammation
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
Loading...
We are here to answer your questions.